nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—Levothyroxine—hypothyroidism	0.112	0.28	CbGbCtD
Citalopram—ABCB1—Liothyronine—hypothyroidism	0.112	0.28	CbGbCtD
Citalopram—ABCB1—Liotrix—hypothyroidism	0.11	0.273	CbGbCtD
Citalopram—CYP3A4—Levothyroxine—hypothyroidism	0.0674	0.168	CbGbCtD
Citalopram—Gagging—Dextrothyroxine—hypothyroidism	0.0186	0.0392	CcSEcCtD
Citalopram—Gagging—Levothyroxine—hypothyroidism	0.0186	0.0392	CcSEcCtD
Citalopram—Choking—Levothyroxine—hypothyroidism	0.0157	0.0332	CcSEcCtD
Citalopram—Choking—Dextrothyroxine—hypothyroidism	0.0157	0.0332	CcSEcCtD
Citalopram—Gagging—Liotrix—hypothyroidism	0.0137	0.0288	CcSEcCtD
Citalopram—Choking—Liotrix—hypothyroidism	0.0116	0.0244	CcSEcCtD
Citalopram—Retching—Dextrothyroxine—hypothyroidism	0.00841	0.0177	CcSEcCtD
Citalopram—Retching—Levothyroxine—hypothyroidism	0.00841	0.0177	CcSEcCtD
Citalopram—Acute bronchitis—Liotrix—hypothyroidism	0.00809	0.0171	CcSEcCtD
Citalopram—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.00727	0.0153	CcSEcCtD
Citalopram—Hyperthyroidism—Levothyroxine—hypothyroidism	0.00727	0.0153	CcSEcCtD
Citalopram—CYP2C19—urine—hypothyroidism	0.00719	0.0761	CbGeAlD
Citalopram—Tracheobronchitis—Liotrix—hypothyroidism	0.007	0.0148	CcSEcCtD
Citalopram—SLC6A3—nerve—hypothyroidism	0.00654	0.0691	CbGeAlD
Citalopram—Tetany—Liotrix—hypothyroidism	0.00648	0.0137	CcSEcCtD
Citalopram—Retching—Liotrix—hypothyroidism	0.00618	0.0131	CcSEcCtD
Citalopram—Muscle twitching—Liothyronine—hypothyroidism	0.00595	0.0126	CcSEcCtD
Citalopram—CYP1A2—urine—hypothyroidism	0.00588	0.0621	CbGeAlD
Citalopram—Hyperthyroidism—Liotrix—hypothyroidism	0.00534	0.0113	CcSEcCtD
Citalopram—CYP2E1—urine—hypothyroidism	0.00529	0.0559	CbGeAlD
Citalopram—SLC6A2—nerve—hypothyroidism	0.00527	0.0558	CbGeAlD
Citalopram—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00519	0.011	CcSEcCtD
Citalopram—Menstruation irregular—Levothyroxine—hypothyroidism	0.00519	0.011	CcSEcCtD
Citalopram—Phlebitis—Liothyronine—hypothyroidism	0.00493	0.0104	CcSEcCtD
Citalopram—Abdominal bloating—Liotrix—hypothyroidism	0.00444	0.00937	CcSEcCtD
Citalopram—Throat tightness—Liotrix—hypothyroidism	0.00431	0.00909	CcSEcCtD
Citalopram—Abdominal cramps—Dextrothyroxine—hypothyroidism	0.00425	0.00898	CcSEcCtD
Citalopram—Abdominal cramps—Levothyroxine—hypothyroidism	0.00425	0.00898	CcSEcCtD
Citalopram—CYP3A4—urine—hypothyroidism	0.00425	0.045	CbGeAlD
Citalopram—CYP2D6—urine—hypothyroidism	0.00418	0.0443	CbGeAlD
Citalopram—Epigastric discomfort—Liotrix—hypothyroidism	0.00402	0.00848	CcSEcCtD
Citalopram—Menstruation irregular—Liotrix—hypothyroidism	0.00382	0.00806	CcSEcCtD
Citalopram—Angina pectoris—Liothyronine—hypothyroidism	0.00357	0.00755	CcSEcCtD
Citalopram—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00322	0.00681	CcSEcCtD
Citalopram—Myocardial infarction—Liothyronine—hypothyroidism	0.00321	0.00677	CcSEcCtD
Citalopram—Abdominal cramps—Liotrix—hypothyroidism	0.00313	0.00661	CcSEcCtD
Citalopram—Cyanosis—Liotrix—hypothyroidism	0.00298	0.0063	CcSEcCtD
Citalopram—Wheezing—Levothyroxine—hypothyroidism	0.00279	0.00589	CcSEcCtD
Citalopram—Wheezing—Dextrothyroxine—hypothyroidism	0.00279	0.00589	CcSEcCtD
Citalopram—Coagulopathy—Liotrix—hypothyroidism	0.00271	0.00573	CcSEcCtD
Citalopram—Feeling hot—Liotrix—hypothyroidism	0.00269	0.00568	CcSEcCtD
Citalopram—Abscess—Liotrix—hypothyroidism	0.00267	0.00564	CcSEcCtD
Citalopram—Coma—Levothyroxine—hypothyroidism	0.00262	0.00554	CcSEcCtD
Citalopram—Coma—Dextrothyroxine—hypothyroidism	0.00262	0.00554	CcSEcCtD
Citalopram—Arrhythmia—Liothyronine—hypothyroidism	0.00262	0.00554	CcSEcCtD
Citalopram—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.0025	0.00529	CcSEcCtD
Citalopram—Hyperkinesia—Levothyroxine—hypothyroidism	0.0025	0.00529	CcSEcCtD
Citalopram—Disorientation—Levothyroxine—hypothyroidism	0.00233	0.00492	CcSEcCtD
Citalopram—Disorientation—Dextrothyroxine—hypothyroidism	0.00233	0.00492	CcSEcCtD
Citalopram—Cellulitis—Liotrix—hypothyroidism	0.00232	0.0049	CcSEcCtD
Citalopram—Hypocalcaemia—Liotrix—hypothyroidism	0.00231	0.00487	CcSEcCtD
Citalopram—Oliguria—Liotrix—hypothyroidism	0.00229	0.00484	CcSEcCtD
Citalopram—Increased appetite—Levothyroxine—hypothyroidism	0.00222	0.00468	CcSEcCtD
Citalopram—Increased appetite—Dextrothyroxine—hypothyroidism	0.00222	0.00468	CcSEcCtD
Citalopram—Hypertension—Liothyronine—hypothyroidism	0.00221	0.00466	CcSEcCtD
Citalopram—Muscle twitching—Liotrix—hypothyroidism	0.00215	0.00454	CcSEcCtD
Citalopram—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00214	0.00451	CcSEcCtD
Citalopram—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00214	0.00451	CcSEcCtD
Citalopram—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00214	0.00451	CcSEcCtD
Citalopram—Cardiac failure—Levothyroxine—hypothyroidism	0.00214	0.00451	CcSEcCtD
Citalopram—CHRM1—cardiovascular system—hypothyroidism	0.00209	0.0221	CbGeAlD
Citalopram—Affect lability—Levothyroxine—hypothyroidism	0.00205	0.00433	CcSEcCtD
Citalopram—Affect lability—Dextrothyroxine—hypothyroidism	0.00205	0.00433	CcSEcCtD
Citalopram—Wheezing—Liotrix—hypothyroidism	0.00205	0.00433	CcSEcCtD
Citalopram—Tachycardia—Liothyronine—hypothyroidism	0.00204	0.0043	CcSEcCtD
Citalopram—Fluid retention—Liotrix—hypothyroidism	0.00201	0.00423	CcSEcCtD
Citalopram—Irritability—Dextrothyroxine—hypothyroidism	0.00199	0.0042	CcSEcCtD
Citalopram—Irritability—Levothyroxine—hypothyroidism	0.00199	0.0042	CcSEcCtD
Citalopram—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00198	0.00419	CcSEcCtD
Citalopram—Cardiac arrest—Levothyroxine—hypothyroidism	0.00198	0.00419	CcSEcCtD
Citalopram—Mood swings—Dextrothyroxine—hypothyroidism	0.00197	0.00417	CcSEcCtD
Citalopram—Mood swings—Levothyroxine—hypothyroidism	0.00197	0.00417	CcSEcCtD
Citalopram—Hypotension—Liothyronine—hypothyroidism	0.00195	0.00412	CcSEcCtD
Citalopram—Dehydration—Levothyroxine—hypothyroidism	0.00194	0.00409	CcSEcCtD
Citalopram—Dehydration—Dextrothyroxine—hypothyroidism	0.00194	0.00409	CcSEcCtD
Citalopram—Coma—Liotrix—hypothyroidism	0.00193	0.00408	CcSEcCtD
Citalopram—Lightheadedness—Liotrix—hypothyroidism	0.00189	0.00399	CcSEcCtD
Citalopram—Hyperkinesia—Liotrix—hypothyroidism	0.00184	0.00389	CcSEcCtD
Citalopram—Muscular weakness—Levothyroxine—hypothyroidism	0.00184	0.00388	CcSEcCtD
Citalopram—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00184	0.00388	CcSEcCtD
Citalopram—Sepsis—Liotrix—hypothyroidism	0.00183	0.00387	CcSEcCtD
Citalopram—ADRA1A—heart—hypothyroidism	0.00182	0.0192	CbGeAlD
Citalopram—Dysphagia—Dextrothyroxine—hypothyroidism	0.0018	0.0038	CcSEcCtD
Citalopram—Dysphagia—Levothyroxine—hypothyroidism	0.0018	0.0038	CcSEcCtD
Citalopram—Phlebitis—Liotrix—hypothyroidism	0.00178	0.00376	CcSEcCtD
Citalopram—Sweating increased—Dextrothyroxine—hypothyroidism	0.00176	0.00371	CcSEcCtD
Citalopram—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00176	0.00371	CcSEcCtD
Citalopram—Sweating increased—Levothyroxine—hypothyroidism	0.00176	0.00371	CcSEcCtD
Citalopram—Angina pectoris—Levothyroxine—hypothyroidism	0.00176	0.00371	CcSEcCtD
Citalopram—ADRA1A—cardiovascular system—hypothyroidism	0.00172	0.0182	CbGeAlD
Citalopram—Disorientation—Liotrix—hypothyroidism	0.00171	0.00362	CcSEcCtD
Citalopram—SLC6A2—gonad—hypothyroidism	0.00168	0.0177	CbGeAlD
Citalopram—Renal failure acute—Liotrix—hypothyroidism	0.00166	0.00351	CcSEcCtD
Citalopram—SLC6A4—blood—hypothyroidism	0.00166	0.0176	CbGeAlD
Citalopram—Body temperature increased—Liothyronine—hypothyroidism	0.00165	0.00348	CcSEcCtD
Citalopram—Increased appetite—Liotrix—hypothyroidism	0.00163	0.00345	CcSEcCtD
Citalopram—Weight decreased—Levothyroxine—hypothyroidism	0.00163	0.00344	CcSEcCtD
Citalopram—Weight decreased—Dextrothyroxine—hypothyroidism	0.00163	0.00344	CcSEcCtD
Citalopram—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00158	0.00334	CcSEcCtD
Citalopram—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00158	0.00334	CcSEcCtD
Citalopram—Myocardial infarction—Levothyroxine—hypothyroidism	0.00157	0.00332	CcSEcCtD
Citalopram—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00157	0.00332	CcSEcCtD
Citalopram—Cardiac failure—Liotrix—hypothyroidism	0.00157	0.00332	CcSEcCtD
Citalopram—Hypoglycaemia—Liotrix—hypothyroidism	0.00157	0.00332	CcSEcCtD
Citalopram—Cerebrovascular accident—Liotrix—hypothyroidism	0.00156	0.0033	CcSEcCtD
Citalopram—Sweating—Dextrothyroxine—hypothyroidism	0.00154	0.00325	CcSEcCtD
Citalopram—Sweating—Levothyroxine—hypothyroidism	0.00154	0.00325	CcSEcCtD
Citalopram—Affect lability—Liotrix—hypothyroidism	0.00151	0.00319	CcSEcCtD
Citalopram—SLC6A3—testis—hypothyroidism	0.0015	0.0158	CbGeAlD
Citalopram—CYP2B6—adrenal cortex—hypothyroidism	0.00149	0.0158	CbGeAlD
Citalopram—Irritability—Liotrix—hypothyroidism	0.00146	0.00309	CcSEcCtD
Citalopram—SLC6A2—adrenal gland—hypothyroidism	0.00146	0.0155	CbGeAlD
Citalopram—Cardiac arrest—Liotrix—hypothyroidism	0.00146	0.00308	CcSEcCtD
Citalopram—Mood swings—Liotrix—hypothyroidism	0.00145	0.00307	CcSEcCtD
Citalopram—CYP2B6—heart—hypothyroidism	0.00144	0.0153	CbGeAlD
Citalopram—Dehydration—Liotrix—hypothyroidism	0.00143	0.00301	CcSEcCtD
Citalopram—Hypokalaemia—Liotrix—hypothyroidism	0.0014	0.00295	CcSEcCtD
Citalopram—SLC6A3—cerebellum—hypothyroidism	0.00138	0.0146	CbGeAlD
Citalopram—CYP2C19—blood—hypothyroidism	0.00138	0.0145	CbGeAlD
Citalopram—CYP2B6—cardiovascular system—hypothyroidism	0.00136	0.0144	CbGeAlD
Citalopram—ADRA1A—adrenal gland—hypothyroidism	0.00136	0.0144	CbGeAlD
Citalopram—ADRA1A—blood—hypothyroidism	0.00136	0.0144	CbGeAlD
Citalopram—Muscular weakness—Liotrix—hypothyroidism	0.00135	0.00286	CcSEcCtD
Citalopram—Flushing—Levothyroxine—hypothyroidism	0.00134	0.00283	CcSEcCtD
Citalopram—Flushing—Dextrothyroxine—hypothyroidism	0.00134	0.00283	CcSEcCtD
Citalopram—Abdominal distension—Liotrix—hypothyroidism	0.00133	0.00282	CcSEcCtD
Citalopram—Dysphagia—Liotrix—hypothyroidism	0.00133	0.0028	CcSEcCtD
Citalopram—Bronchospasm—Liotrix—hypothyroidism	0.0013	0.00275	CcSEcCtD
Citalopram—Sweating increased—Liotrix—hypothyroidism	0.00129	0.00273	CcSEcCtD
Citalopram—Angina pectoris—Liotrix—hypothyroidism	0.00129	0.00273	CcSEcCtD
Citalopram—Arrhythmia—Levothyroxine—hypothyroidism	0.00129	0.00272	CcSEcCtD
Citalopram—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00129	0.00272	CcSEcCtD
Citalopram—CYP2E1—cardiovascular system—hypothyroidism	0.00128	0.0135	CbGeAlD
Citalopram—Bronchitis—Liotrix—hypothyroidism	0.00127	0.00269	CcSEcCtD
Citalopram—Alopecia—Dextrothyroxine—hypothyroidism	0.00127	0.00269	CcSEcCtD
Citalopram—Alopecia—Levothyroxine—hypothyroidism	0.00127	0.00269	CcSEcCtD
Citalopram—CYP2B6—gonad—hypothyroidism	0.00124	0.0131	CbGeAlD
Citalopram—Tension—Dextrothyroxine—hypothyroidism	0.00123	0.0026	CcSEcCtD
Citalopram—Tension—Levothyroxine—hypothyroidism	0.00123	0.0026	CcSEcCtD
Citalopram—Nervousness—Dextrothyroxine—hypothyroidism	0.00122	0.00257	CcSEcCtD
Citalopram—Nervousness—Levothyroxine—hypothyroidism	0.00122	0.00257	CcSEcCtD
Citalopram—SLC6A2—testis—hypothyroidism	0.00121	0.0128	CbGeAlD
Citalopram—Weight decreased—Liotrix—hypothyroidism	0.0012	0.00253	CcSEcCtD
Citalopram—Tremor—Dextrothyroxine—hypothyroidism	0.00118	0.00248	CcSEcCtD
Citalopram—Tremor—Levothyroxine—hypothyroidism	0.00118	0.00248	CcSEcCtD
Citalopram—Acute coronary syndrome—Liotrix—hypothyroidism	0.00116	0.00246	CcSEcCtD
Citalopram—Myocardial infarction—Liotrix—hypothyroidism	0.00116	0.00245	CcSEcCtD
Citalopram—Agitation—Dextrothyroxine—hypothyroidism	0.00115	0.00244	CcSEcCtD
Citalopram—Agitation—Levothyroxine—hypothyroidism	0.00115	0.00244	CcSEcCtD
Citalopram—Angioedema—Dextrothyroxine—hypothyroidism	0.00115	0.00242	CcSEcCtD
Citalopram—Angioedema—Levothyroxine—hypothyroidism	0.00115	0.00242	CcSEcCtD
Citalopram—Sweating—Liotrix—hypothyroidism	0.00113	0.00239	CcSEcCtD
Citalopram—CYP1A2—blood—hypothyroidism	0.00112	0.0119	CbGeAlD
Citalopram—Palpitations—Dextrothyroxine—hypothyroidism	0.00111	0.00234	CcSEcCtD
Citalopram—Palpitations—Levothyroxine—hypothyroidism	0.00111	0.00234	CcSEcCtD
Citalopram—Convulsion—Levothyroxine—hypothyroidism	0.00109	0.0023	CcSEcCtD
Citalopram—Convulsion—Dextrothyroxine—hypothyroidism	0.00109	0.0023	CcSEcCtD
Citalopram—CYP1A2—thyroid gland—hypothyroidism	0.00108	0.0115	CbGeAlD
Citalopram—CYP2B6—adrenal gland—hypothyroidism	0.00108	0.0114	CbGeAlD
Citalopram—CYP2B6—blood—hypothyroidism	0.00108	0.0114	CbGeAlD
Citalopram—CYP2C19—liver—hypothyroidism	0.00108	0.0114	CbGeAlD
Citalopram—Arthralgia—Levothyroxine—hypothyroidism	0.00107	0.00226	CcSEcCtD
Citalopram—Arthralgia—Dextrothyroxine—hypothyroidism	0.00107	0.00226	CcSEcCtD
Citalopram—Anxiety—Levothyroxine—hypothyroidism	0.00107	0.00225	CcSEcCtD
Citalopram—Anxiety—Dextrothyroxine—hypothyroidism	0.00107	0.00225	CcSEcCtD
Citalopram—ADRA1A—liver—hypothyroidism	0.00106	0.0112	CbGeAlD
Citalopram—Hypoaesthesia—Liotrix—hypothyroidism	0.00106	0.00223	CcSEcCtD
Citalopram—HRH1—adrenal gland—hypothyroidism	0.00105	0.0111	CbGeAlD
Citalopram—ADRA1A—cerebellum—hypothyroidism	0.00104	0.011	CbGeAlD
Citalopram—Confusional state—Dextrothyroxine—hypothyroidism	0.00103	0.00218	CcSEcCtD
Citalopram—Confusional state—Levothyroxine—hypothyroidism	0.00103	0.00218	CcSEcCtD
Citalopram—CYP2E1—adrenal gland—hypothyroidism	0.00101	0.0107	CbGeAlD
Citalopram—CYP2E1—blood—hypothyroidism	0.00101	0.0107	CbGeAlD
Citalopram—Shock—Dextrothyroxine—hypothyroidism	0.00101	0.00213	CcSEcCtD
Citalopram—Shock—Levothyroxine—hypothyroidism	0.00101	0.00213	CcSEcCtD
Citalopram—Tachycardia—Dextrothyroxine—hypothyroidism	0.001	0.00211	CcSEcCtD
Citalopram—Tachycardia—Levothyroxine—hypothyroidism	0.001	0.00211	CcSEcCtD
Citalopram—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000991	0.00209	CcSEcCtD
Citalopram—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000991	0.00209	CcSEcCtD
Citalopram—Flushing—Liotrix—hypothyroidism	0.000985	0.00208	CcSEcCtD
Citalopram—HRH1—female gonad—hypothyroidism	0.000981	0.0104	CbGeAlD
Citalopram—CYP2E1—thyroid gland—hypothyroidism	0.000975	0.0103	CbGeAlD
Citalopram—Arrhythmia—Liotrix—hypothyroidism	0.000948	0.002	CcSEcCtD
Citalopram—Alopecia—Liotrix—hypothyroidism	0.000937	0.00198	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000933	0.00197	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000933	0.00197	CcSEcCtD
Citalopram—Insomnia—Levothyroxine—hypothyroidism	0.000927	0.00196	CcSEcCtD
Citalopram—Insomnia—Dextrothyroxine—hypothyroidism	0.000927	0.00196	CcSEcCtD
Citalopram—Dyspnoea—Levothyroxine—hypothyroidism	0.000913	0.00193	CcSEcCtD
Citalopram—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000913	0.00193	CcSEcCtD
Citalopram—Flatulence—Liotrix—hypothyroidism	0.00091	0.00192	CcSEcCtD
Citalopram—Tension—Liotrix—hypothyroidism	0.000906	0.00191	CcSEcCtD
Citalopram—Dysgeusia—Liotrix—hypothyroidism	0.000904	0.00191	CcSEcCtD
Citalopram—Nervousness—Liotrix—hypothyroidism	0.000897	0.00189	CcSEcCtD
Citalopram—CYP2B6—testis—hypothyroidism	0.000891	0.00942	CbGeAlD
Citalopram—Fatigue—Levothyroxine—hypothyroidism	0.000883	0.00187	CcSEcCtD
Citalopram—Fatigue—Dextrothyroxine—hypothyroidism	0.000883	0.00187	CcSEcCtD
Citalopram—CYP1A2—liver—hypothyroidism	0.000878	0.00929	CbGeAlD
Citalopram—Vision blurred—Liotrix—hypothyroidism	0.00087	0.00184	CcSEcCtD
Citalopram—HRH1—testis—hypothyroidism	0.00087	0.0092	CbGeAlD
Citalopram—Tremor—Liotrix—hypothyroidism	0.000865	0.00183	CcSEcCtD
Citalopram—Agitation—Liotrix—hypothyroidism	0.000849	0.00179	CcSEcCtD
Citalopram—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000844	0.00178	CcSEcCtD
Citalopram—Feeling abnormal—Levothyroxine—hypothyroidism	0.000844	0.00178	CcSEcCtD
Citalopram—Angioedema—Liotrix—hypothyroidism	0.000844	0.00178	CcSEcCtD
Citalopram—CYP2B6—liver—hypothyroidism	0.000842	0.0089	CbGeAlD
Citalopram—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000838	0.00177	CcSEcCtD
Citalopram—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000838	0.00177	CcSEcCtD
Citalopram—CYP2E1—testis—hypothyroidism	0.000836	0.00884	CbGeAlD
Citalopram—Syncope—Liotrix—hypothyroidism	0.000828	0.00175	CcSEcCtD
Citalopram—Palpitations—Liotrix—hypothyroidism	0.000816	0.00172	CcSEcCtD
Citalopram—Urticaria—Levothyroxine—hypothyroidism	0.000814	0.00172	CcSEcCtD
Citalopram—Urticaria—Dextrothyroxine—hypothyroidism	0.000814	0.00172	CcSEcCtD
Citalopram—CYP3A4—blood—hypothyroidism	0.000813	0.0086	CbGeAlD
Citalopram—Loss of consciousness—Liotrix—hypothyroidism	0.000812	0.00171	CcSEcCtD
Citalopram—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00081	0.00171	CcSEcCtD
Citalopram—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00081	0.00171	CcSEcCtD
Citalopram—Body temperature increased—Levothyroxine—hypothyroidism	0.00081	0.00171	CcSEcCtD
Citalopram—Abdominal pain—Levothyroxine—hypothyroidism	0.00081	0.00171	CcSEcCtD
Citalopram—Convulsion—Liotrix—hypothyroidism	0.0008	0.00169	CcSEcCtD
Citalopram—CYP2D6—blood—hypothyroidism	0.0008	0.00846	CbGeAlD
Citalopram—ABCB1—adrenal cortex—hypothyroidism	0.000797	0.00843	CbGeAlD
Citalopram—Hypertension—Liotrix—hypothyroidism	0.000797	0.00168	CcSEcCtD
Citalopram—CYP2E1—liver—hypothyroidism	0.00079	0.00836	CbGeAlD
Citalopram—Arthralgia—Liotrix—hypothyroidism	0.000786	0.00166	CcSEcCtD
Citalopram—Chest pain—Liotrix—hypothyroidism	0.000786	0.00166	CcSEcCtD
Citalopram—Anxiety—Liotrix—hypothyroidism	0.000783	0.00165	CcSEcCtD
Citalopram—CYP2E1—cerebellum—hypothyroidism	0.000772	0.00816	CbGeAlD
Citalopram—ABCB1—heart—hypothyroidism	0.000771	0.00816	CbGeAlD
Citalopram—Confusional state—Liotrix—hypothyroidism	0.00076	0.0016	CcSEcCtD
Citalopram—Anaphylactic shock—Liotrix—hypothyroidism	0.000754	0.00159	CcSEcCtD
Citalopram—Oedema—Liotrix—hypothyroidism	0.000754	0.00159	CcSEcCtD
Citalopram—Infection—Liotrix—hypothyroidism	0.000749	0.00158	CcSEcCtD
Citalopram—CYP2D6—female gonad—hypothyroidism	0.000746	0.00789	CbGeAlD
Citalopram—Shock—Liotrix—hypothyroidism	0.000741	0.00157	CcSEcCtD
Citalopram—Tachycardia—Liotrix—hypothyroidism	0.000736	0.00155	CcSEcCtD
Citalopram—Asthenia—Levothyroxine—hypothyroidism	0.000735	0.00155	CcSEcCtD
Citalopram—Asthenia—Dextrothyroxine—hypothyroidism	0.000735	0.00155	CcSEcCtD
Citalopram—Hyperhidrosis—Liotrix—hypothyroidism	0.000729	0.00154	CcSEcCtD
Citalopram—ABCB1—cardiovascular system—hypothyroidism	0.000728	0.0077	CbGeAlD
Citalopram—Pruritus—Levothyroxine—hypothyroidism	0.000725	0.00153	CcSEcCtD
Citalopram—Pruritus—Dextrothyroxine—hypothyroidism	0.000725	0.00153	CcSEcCtD
Citalopram—Anorexia—Liotrix—hypothyroidism	0.000718	0.00152	CcSEcCtD
Citalopram—Hypotension—Liotrix—hypothyroidism	0.000704	0.00149	CcSEcCtD
Citalopram—Diarrhoea—Levothyroxine—hypothyroidism	0.000701	0.00148	CcSEcCtD
Citalopram—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000701	0.00148	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000687	0.00145	CcSEcCtD
Citalopram—Insomnia—Liotrix—hypothyroidism	0.000682	0.00144	CcSEcCtD
Citalopram—Paraesthesia—Liotrix—hypothyroidism	0.000677	0.00143	CcSEcCtD
Citalopram—Dyspnoea—Liotrix—hypothyroidism	0.000672	0.00142	CcSEcCtD
Citalopram—CYP2D6—testis—hypothyroidism	0.000662	0.007	CbGeAlD
Citalopram—ABCB1—gonad—hypothyroidism	0.000661	0.00698	CbGeAlD
Citalopram—Decreased appetite—Liotrix—hypothyroidism	0.000655	0.00138	CcSEcCtD
Citalopram—Vomiting—Dextrothyroxine—hypothyroidism	0.000651	0.00138	CcSEcCtD
Citalopram—Vomiting—Levothyroxine—hypothyroidism	0.000651	0.00138	CcSEcCtD
Citalopram—Fatigue—Liotrix—hypothyroidism	0.00065	0.00137	CcSEcCtD
Citalopram—Rash—Dextrothyroxine—hypothyroidism	0.000646	0.00136	CcSEcCtD
Citalopram—Rash—Levothyroxine—hypothyroidism	0.000646	0.00136	CcSEcCtD
Citalopram—Dermatitis—Levothyroxine—hypothyroidism	0.000645	0.00136	CcSEcCtD
Citalopram—Dermatitis—Dextrothyroxine—hypothyroidism	0.000645	0.00136	CcSEcCtD
Citalopram—Constipation—Liotrix—hypothyroidism	0.000644	0.00136	CcSEcCtD
Citalopram—ABCB1—pituitary gland—hypothyroidism	0.000644	0.00681	CbGeAlD
Citalopram—Headache—Dextrothyroxine—hypothyroidism	0.000642	0.00136	CcSEcCtD
Citalopram—Headache—Levothyroxine—hypothyroidism	0.000642	0.00136	CcSEcCtD
Citalopram—CYP3A4—liver—hypothyroidism	0.000636	0.00672	CbGeAlD
Citalopram—CYP2D6—liver—hypothyroidism	0.000626	0.00662	CbGeAlD
Citalopram—Feeling abnormal—Liotrix—hypothyroidism	0.000621	0.00131	CcSEcCtD
Citalopram—Gastrointestinal pain—Liotrix—hypothyroidism	0.000616	0.0013	CcSEcCtD
Citalopram—CYP2D6—cerebellum—hypothyroidism	0.000611	0.00646	CbGeAlD
Citalopram—Nausea—Dextrothyroxine—hypothyroidism	0.000609	0.00128	CcSEcCtD
Citalopram—Nausea—Levothyroxine—hypothyroidism	0.000609	0.00128	CcSEcCtD
Citalopram—Urticaria—Liotrix—hypothyroidism	0.000599	0.00126	CcSEcCtD
Citalopram—Abdominal pain—Liotrix—hypothyroidism	0.000596	0.00126	CcSEcCtD
Citalopram—Body temperature increased—Liotrix—hypothyroidism	0.000596	0.00126	CcSEcCtD
Citalopram—ABCB1—adrenal gland—hypothyroidism	0.000576	0.00609	CbGeAlD
Citalopram—ABCB1—blood—hypothyroidism	0.000576	0.00609	CbGeAlD
Citalopram—ABCB1—thyroid gland—hypothyroidism	0.000555	0.00587	CbGeAlD
Citalopram—Hypersensitivity—Liotrix—hypothyroidism	0.000555	0.00117	CcSEcCtD
Citalopram—Asthenia—Liotrix—hypothyroidism	0.000541	0.00114	CcSEcCtD
Citalopram—ABCB1—female gonad—hypothyroidism	0.000537	0.00568	CbGeAlD
Citalopram—Pruritus—Liotrix—hypothyroidism	0.000533	0.00113	CcSEcCtD
Citalopram—Diarrhoea—Liotrix—hypothyroidism	0.000516	0.00109	CcSEcCtD
Citalopram—Dizziness—Liotrix—hypothyroidism	0.000498	0.00105	CcSEcCtD
Citalopram—Vomiting—Liotrix—hypothyroidism	0.000479	0.00101	CcSEcCtD
Citalopram—ABCB1—testis—hypothyroidism	0.000476	0.00503	CbGeAlD
Citalopram—Rash—Liotrix—hypothyroidism	0.000475	0.001	CcSEcCtD
Citalopram—Dermatitis—Liotrix—hypothyroidism	0.000475	0.001	CcSEcCtD
Citalopram—Headache—Liotrix—hypothyroidism	0.000472	0.000997	CcSEcCtD
Citalopram—ABCB1—liver—hypothyroidism	0.00045	0.00476	CbGeAlD
Citalopram—Nausea—Liotrix—hypothyroidism	0.000448	0.000945	CcSEcCtD
Citalopram—ABCB1—cerebellum—hypothyroidism	0.00044	0.00465	CbGeAlD
Citalopram—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000383	0.0129	CbGpPWpGaD
Citalopram—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000354	0.0119	CbGpPWpGaD
Citalopram—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000324	0.0109	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000287	0.00965	CbGpPWpGaD
Citalopram—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.000271	0.00912	CbGpPWpGaD
Citalopram—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000268	0.00903	CbGpPWpGaD
Citalopram—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000239	0.00804	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000238	0.008	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000229	0.00772	CbGpPWpGaD
Citalopram—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000228	0.00767	CbGpPWpGaD
Citalopram—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000205	0.00691	CbGpPWpGaD
Citalopram—HTR2C—G alpha (q) signalling events—TRH—hypothyroidism	0.000203	0.00685	CbGpPWpGaD
Citalopram—ADRA1A—G alpha (12/13) signalling events—VAV3—hypothyroidism	0.000196	0.0066	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000182	0.00613	CbGpPWpGaD
Citalopram—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000182	0.00612	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000178	0.006	CbGpPWpGaD
Citalopram—HRH1—G alpha (q) signalling events—TRH—hypothyroidism	0.000176	0.00594	CbGpPWpGaD
Citalopram—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.000176	0.00592	CbGpPWpGaD
Citalopram—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000175	0.00588	CbGpPWpGaD
Citalopram—ADRA1A—G alpha (q) signalling events—TRH—hypothyroidism	0.000173	0.00582	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000167	0.00564	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000165	0.00554	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000158	0.00531	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000157	0.00529	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000155	0.00521	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000146	0.00491	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000146	0.0049	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000136	0.00459	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000135	0.00454	CbGpPWpGaD
Citalopram—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000131	0.0044	CbGpPWpGaD
Citalopram—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000129	0.00436	CbGpPWpGaD
Citalopram—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000128	0.00431	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000121	0.00407	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00012	0.00404	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00012	0.00404	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000117	0.00393	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000116	0.00392	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000115	0.00386	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000115	0.00386	CbGpPWpGaD
Citalopram—HTR2C—G alpha (q) signalling events—AVP—hypothyroidism	0.000107	0.0036	CbGpPWpGaD
Citalopram—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000106	0.00357	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000104	0.0035	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000104	0.0035	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000104	0.00349	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000104	0.00349	CbGpPWpGaD
Citalopram—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000104	0.00349	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—TRH—hypothyroidism	0.000103	0.00345	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000102	0.00344	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000102	0.00344	CbGpPWpGaD
Citalopram—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000102	0.00343	CbGpPWpGaD
Citalopram—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.87e-05	0.00332	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	9.56e-05	0.00322	CbGpPWpGaD
Citalopram—HRH1—G alpha (q) signalling events—AVP—hypothyroidism	9.26e-05	0.00312	CbGpPWpGaD
Citalopram—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	9.23e-05	0.00311	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—TSHB—hypothyroidism	9.15e-05	0.00308	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—TSHR—hypothyroidism	9.15e-05	0.00308	CbGpPWpGaD
Citalopram—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	9.09e-05	0.00306	CbGpPWpGaD
Citalopram—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.08e-05	0.00306	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	9.02e-05	0.00304	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—TRH—hypothyroidism	8.89e-05	0.00299	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—TRH—hypothyroidism	8.86e-05	0.00298	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	8.73e-05	0.00294	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	8.71e-05	0.00293	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	8.28e-05	0.00279	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	8.26e-05	0.00278	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	8.13e-05	0.00274	CbGpPWpGaD
Citalopram—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8e-05	0.00269	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—TSHB—hypothyroidism	7.93e-05	0.00267	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—TSHR—hypothyroidism	7.93e-05	0.00267	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	7.9e-05	0.00266	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	7.9e-05	0.00266	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	7.78e-05	0.00262	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	7.78e-05	0.00262	CbGpPWpGaD
Citalopram—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.69e-05	0.00259	CbGpPWpGaD
Citalopram—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.36e-05	0.00248	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.24e-05	0.00244	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	7.08e-05	0.00238	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—IYD—hypothyroidism	6.64e-05	0.00223	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.58e-05	0.00221	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—IYD—hypothyroidism	6.5e-05	0.00219	CbGpPWpGaD
Citalopram—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.24e-05	0.0021	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.13e-05	0.00207	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.11e-05	0.00206	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.02e-05	0.00203	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6e-05	0.00202	CbGpPWpGaD
Citalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.94e-05	0.002	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.83e-05	0.00196	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	5.8e-05	0.00195	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ATP5O—hypothyroidism	5.64e-05	0.0019	CbGpPWpGaD
Citalopram—CYP2B6—Biological oxidations—POMC—hypothyroidism	5.63e-05	0.00189	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ATP5O—hypothyroidism	5.53e-05	0.00186	CbGpPWpGaD
Citalopram—CYP2E1—Biological oxidations—POMC—hypothyroidism	5.51e-05	0.00185	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—AVP—hypothyroidism	5.39e-05	0.00181	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—TPO—hypothyroidism	5.31e-05	0.00179	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TRH—hypothyroidism	5.27e-05	0.00177	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—TPO—hypothyroidism	5.2e-05	0.00175	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	5.18e-05	0.00174	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	5.17e-05	0.00174	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	5.17e-05	0.00174	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—TRH—hypothyroidism	5.03e-05	0.00169	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—IYD—hypothyroidism	5.02e-05	0.00169	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	5.01e-05	0.00169	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	4.93e-05	0.00166	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—IYD—hypothyroidism	4.89e-05	0.00165	CbGpPWpGaD
Citalopram—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.81e-05	0.00162	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.7e-05	0.00158	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	4.69e-05	0.00158	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	4.69e-05	0.00158	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—AVP—hypothyroidism	4.67e-05	0.00157	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—AVP—hypothyroidism	4.66e-05	0.00157	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—IYD—hypothyroidism	4.61e-05	0.00155	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	4.59e-05	0.00154	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	4.58e-05	0.00154	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TRH—hypothyroidism	4.56e-05	0.00154	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TRH—hypothyroidism	4.55e-05	0.00153	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	4.48e-05	0.00151	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	4.48e-05	0.00151	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	4.48e-05	0.00151	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	4.46e-05	0.0015	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	4.46e-05	0.0015	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	4.4e-05	0.00148	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	4.4e-05	0.00148	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ATP5O—hypothyroidism	4.26e-05	0.00144	CbGpPWpGaD
Citalopram—CYP2C19—Biological oxidations—POMC—hypothyroidism	4.25e-05	0.00143	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ATP5O—hypothyroidism	4.16e-05	0.0014	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.08e-05	0.00137	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TSHB—hypothyroidism	4.07e-05	0.00137	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TSHR—hypothyroidism	4.07e-05	0.00137	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.06e-05	0.00137	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	4.05e-05	0.00136	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	4.05e-05	0.00136	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TPO—hypothyroidism	4.01e-05	0.00135	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4e-05	0.00135	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	3.99e-05	0.00134	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	3.99e-05	0.00134	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ATP5O—hypothyroidism	3.92e-05	0.00132	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TPO—hypothyroidism	3.91e-05	0.00132	CbGpPWpGaD
Citalopram—CYP2D6—Biological oxidations—POMC—hypothyroidism	3.91e-05	0.00132	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—IYD—hypothyroidism	3.91e-05	0.00132	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.71e-05	0.00125	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TPO—hypothyroidism	3.69e-05	0.00124	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.67e-05	0.00124	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CLTC—hypothyroidism	3.6e-05	0.00121	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—POMC—hypothyroidism	3.58e-05	0.00121	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ATP5O—hypothyroidism	3.32e-05	0.00112	CbGpPWpGaD
Citalopram—CYP1A2—Biological oxidations—POMC—hypothyroidism	3.31e-05	0.00112	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	3.16e-05	0.00106	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TPO—hypothyroidism	3.12e-05	0.00105	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CLTC—hypothyroidism	3.12e-05	0.00105	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TRH—hypothyroidism	3.11e-05	0.00105	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CLTC—hypothyroidism	3.11e-05	0.00105	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—POMC—hypothyroidism	3.1e-05	0.00105	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—POMC—hypothyroidism	3.09e-05	0.00104	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	3.06e-05	0.00103	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	3.05e-05	0.00103	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	3.05e-05	0.00103	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—IYD—hypothyroidism	3.02e-05	0.00102	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.9e-05	0.000975	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.89e-05	0.000974	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	2.87e-05	0.000967	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TSHB—hypothyroidism	2.77e-05	0.000933	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TSHR—hypothyroidism	2.77e-05	0.000933	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AVP—hypothyroidism	2.77e-05	0.000931	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	2.74e-05	0.000922	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	2.73e-05	0.000919	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TRH—hypothyroidism	2.7e-05	0.000908	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	2.69e-05	0.000905	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TRH—hypothyroidism	2.69e-05	0.000905	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TRH—hypothyroidism	2.65e-05	0.000891	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AVP—hypothyroidism	2.64e-05	0.000889	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	2.63e-05	0.000886	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	2.59e-05	0.000872	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.56e-05	0.000863	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.56e-05	0.000861	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—VAV3—hypothyroidism	2.49e-05	0.000838	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	2.48e-05	0.000835	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	2.47e-05	0.000832	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—TSHB—hypothyroidism	2.46e-05	0.000827	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	2.44e-05	0.000822	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TPO—hypothyroidism	2.41e-05	0.000812	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—TSHB—hypothyroidism	2.41e-05	0.00081	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TSHB—hypothyroidism	2.4e-05	0.000809	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TSHR—hypothyroidism	2.4e-05	0.000809	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AVP—hypothyroidism	2.4e-05	0.000807	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TSHR—hypothyroidism	2.4e-05	0.000806	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TSHB—hypothyroidism	2.4e-05	0.000806	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AVP—hypothyroidism	2.39e-05	0.000804	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	2.36e-05	0.000794	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	2.36e-05	0.000794	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	2.35e-05	0.000792	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.28e-05	0.000767	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	2.19e-05	0.000737	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	2.14e-05	0.000722	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SH2B3—hypothyroidism	2.14e-05	0.000721	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	2.13e-05	0.000719	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	2.1e-05	0.000707	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	2.02e-05	0.000682	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TSHB—hypothyroidism	1.86e-05	0.000625	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SLC5A5—hypothyroidism	1.84e-05	0.000619	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—POMC—hypothyroidism	1.84e-05	0.000619	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRL—hypothyroidism	1.83e-05	0.000617	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TSHB—hypothyroidism	1.81e-05	0.00061	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SLC5A5—hypothyroidism	1.8e-05	0.000606	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—POMC—hypothyroidism	1.75e-05	0.000591	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	1.75e-05	0.000589	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	1.72e-05	0.000579	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TSHB—hypothyroidism	1.71e-05	0.000575	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VAV3—hypothyroidism	1.7e-05	0.000571	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.65e-05	0.000557	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AVP—hypothyroidism	1.63e-05	0.00055	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.63e-05	0.00055	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.61e-05	0.000544	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—POMC—hypothyroidism	1.59e-05	0.000536	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRL—hypothyroidism	1.59e-05	0.000535	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—POMC—hypothyroidism	1.59e-05	0.000535	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRL—hypothyroidism	1.58e-05	0.000533	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	1.56e-05	0.000526	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRL—hypothyroidism	1.56e-05	0.000525	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.52e-05	0.000512	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VAV3—hypothyroidism	1.47e-05	0.000495	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VAV3—hypothyroidism	1.47e-05	0.000493	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TSHB—hypothyroidism	1.45e-05	0.000487	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	1.44e-05	0.000486	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AVP—hypothyroidism	1.42e-05	0.000477	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AVP—hypothyroidism	1.41e-05	0.000475	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AVP—hypothyroidism	1.39e-05	0.000468	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SLC5A5—hypothyroidism	1.39e-05	0.000468	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.36e-05	0.000457	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.29e-05	0.000434	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.28e-05	0.00043	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.27e-05	0.000428	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TSHB—hypothyroidism	1.12e-05	0.000376	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—POMC—hypothyroidism	1.09e-05	0.000366	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.08e-05	0.000364	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1—hypothyroidism	1.04e-05	0.000352	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	9.95e-06	0.000335	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—hypothyroidism	9.62e-06	0.000324	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—hypothyroidism	9.42e-06	0.000317	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—hypothyroidism	9.41e-06	0.000317	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—hypothyroidism	9.38e-06	0.000316	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—hypothyroidism	9.23e-06	0.000311	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—hypothyroidism	9.05e-06	0.000305	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—hypothyroidism	9.02e-06	0.000304	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	8.88e-06	0.000299	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC5A5—hypothyroidism	8.36e-06	0.000281	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—hypothyroidism	7.27e-06	0.000245	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—hypothyroidism	7.1e-06	0.000239	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—hypothyroidism	6.69e-06	0.000225	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—hypothyroidism	5.66e-06	0.000191	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—hypothyroidism	4.37e-06	0.000147	CbGpPWpGaD
